Table 1 The characteristics of fatal and non-fatal overdoses

Total

35,569

30,957 (87)

4612 (13)

Urbanicity

Large

24,856 (69.9)

21,905 (70.8)

2951 (64)

Medium

5485 (15.4)

4725 (15.3)

760 (16.5)

Small

3028 (8.5)

2547 (8.2)

481 (10.4)

Rural

2200 (6.2)

1780 (5.7)

420 (9.1)

Location Type

Private

17,551 (49.3)

13,733 (44.4)

3818 (82.8)

Public Buildings

5123 (14.4)

5031 (16.3)

92 (2)

Healthcare Facilities

811 (2.3)

775 (2.5)

36 (0.8)

Outdoor

9917 (27.9)

9546 (30.8)

371 (8)

Others

2167 (6.1)

1872 (6)

295 (6.4)

Recurrent Event

No

21,450 (60.3)

17,958 (58)

3492 (75.7)

Yes

14,119 (39.7)

12,999 (42)

1120 (24.3)

Age

18–29

10,873 (30.6)

10,019 (32.4)

854 (18.5)

< 18

783 (2.2)

746 (2.4)

37 (0.8)

30–49

16,159 (45.4)

14,035 (45.3)

2124 (46.1)

50–64

6381 (17.9)

5093 (16.5)

1288 (27.9)

≥65

1373 (3.9)

1064 (3.4)

309 (6.7)

Sex

F

10,078 (28.3)

9098 (29.4)

980 (21.2)

M

25,491 (71.7)

21,859 (70.6)

3632 (78.8)

Benzodiazepines Prescriptions

No

33,162 (93.2)

28,982 (93.6)

4180 (90.6)

Yes

2407 (6.8)

1975 (6.4)

432 (9.4)

Other Sedatives Prescriptions

No

24,740 (69.6)

21,640 (69.9)

3100 (67.2)

Yes

10,829 (30.4)

9317 (30.1)

1512 (32.8)

Opioids for pain Prescriptions

No

33,254 (93.5)

29,073 (93.9)

4181 (90.7)

Yes

2315 (6.5)

1884 (6.1)

431 (9.3)

Social Deprivation²

Q3

4824 (13.6)

4195 (13.6)

629 (13.6)

Q1

3143 (8.8)

2658 (8.6)

485 (10.5)

Q2

4966 (14)

4297 (13.9)

669 (14.5)

Q4

6499 (18.3)

5658 (18.3)

841 (18.2)

Q5

16,137 (45.4)

14,149 (45.7)

1988 (43.1)

Year

2015–2016

13,374 (37.6)

11,820 (38.2)

1554 (33.7)

2017–2018

22,195 (62.4)

19,137 (61.8)

3058 (66.3)